50 related articles for article (PubMed ID: 36724527)
1. Pre-frailty after blood or marrow transplantation and the risk of subsequent mortality.
Balas N; Richman JS; Landier W; Shrestha S; Bruxvoort KJ; Hageman L; Meng Q; Ross E; Bosworth A; Wong FL; Bhatia R; Forman SJ; Armenian SH; Weisdorf DJ; Bhatia S
Leukemia; 2024 Apr; ():. PubMed ID: 38580835
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537
[TBL] [Abstract][Full Text] [Related]
3. How I monitor long-term and late effects after blood or marrow transplantation.
Bhatia S; Armenian SH; Landier W
Blood; 2017 Sep; 130(11):1302-1314. PubMed ID: 28743716
[TBL] [Abstract][Full Text] [Related]
4. Risk of COVID-19 infection in long-term survivors of blood or marrow transplantation: a BMTSS report.
Johnston EE; Meng Q; Hageman L; Wu J; Ross E; Lim S; Balas N; Bosworth A; Te HS; Francisco L; Bhatia R; Forman SJ; Wong FL; Armenian SH; Weisdorf DJ; Landier W; Bhatia S
Blood Adv; 2023 Jun; 7(12):2843-2854. PubMed ID: 36724527
[TBL] [Abstract][Full Text] [Related]
5. Financial Burden in Blood or Marrow Transplantation Survivors During the COVID-19 Pandemic: A BMTSS Report.
Bhatia S; Dai C; Hageman L; Wu J; Schlichting E; Siler A; Funk E; Hicks J; Lim S; Balas N; Bosworth A; Te HS; Francisco L; Bhatia R; Forman SJ; Wong FL; Arora M; Armenian SH; Weisdorf DJ; Landier W
J Clin Oncol; 2023 Feb; 41(5):1011-1022. PubMed ID: 36455192
[TBL] [Abstract][Full Text] [Related]
6. Health care utilization by long-term survivors of blood or marrow transplantation-A Bone Marrow Transplant Survivor Study report.
Oliver MM; Meng Q; Hageman L; Landier W; Balas N; Ross E; Francisco L; Bosworth A; Te HS; Wong FL; Bhatia R; Forman SJ; Armenian SH; Weisdorf DJ; Bhatia S
Cancer; 2024 Mar; 130(5):803-815. PubMed ID: 37880912
[TBL] [Abstract][Full Text] [Related]
7. Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model.
Gangaraju R; Chen Y; Hageman L; Wu J; Francisco L; Kung M; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
Blood Adv; 2021 Oct; 5(20):4102-4111. PubMed ID: 34461633
[TBL] [Abstract][Full Text] [Related]
8. Total Body Irradiation and Risk of Breast Cancer After Blood or Marrow Transplantation: A Blood or Marrow Transplantation Survivor Study Report.
McDonald AM; Chen Y; Wu J; Hageman L; Francisco L; Kung M; Wong FL; Ness E; Landier W; Battles K; Salzman D; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
J Clin Oncol; 2020 Sep; 38(25):2872-2882. PubMed ID: 32673169
[TBL] [Abstract][Full Text] [Related]
9. Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades: A Blood or Marrow Transplant Survivor Study Report.
Bhatia S; Dai C; Landier W; Hageman L; Wu J; Schlichting E; Siler A; Funk E; Hicks J; Bosworth A; Te HS; Francisco L; Bhatia R; Salzman D; Goldman FD; Forman SJ; Weisdorf DJ; Wong FL; Arora M; Armenian SH
JAMA Oncol; 2021 Nov; 7(11):1626-1634. PubMed ID: 34499078
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of observational methods used to quantify personal protective behaviours among members of the public during the COVID-19 pandemic, and the concordance between observational and self-report measures in infectious disease health protection.
Davies R; Mowbray F; Martin AF; Smith LE; Rubin GJ
BMC Public Health; 2022 Jul; 22(1):1436. PubMed ID: 35902818
[TBL] [Abstract][Full Text] [Related]
11. Secondary Impact of the Coronavirus Disease 19 Pandemic on Patients and the Cellular Therapy Healthcare Ecosystem.
Koo J; Auletta JJ; Hartley DM; Huber J; Jaglowski S; Kapadia M; Kusnier K; Lehmann L; Maakaron J; Myers KC; Pai A; Parker L; Phelan R; Sper C; Rotz SJ; Dandoy CE
Transplant Cell Ther; 2022 Nov; 28(11):737-746. PubMed ID: 35902050
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Cohort Study.
Bhatt NS; Sharma A; St Martin A; Abid MB; Brown VI; Diaz Perez MA; Frangoul H; Gadalla SM; Herr MM; Krem MM; Lazarus HM; Martens MJ; Mehta PA; Nishihori T; Prestidge T; Pulsipher MA; Rangarajan HG; Williams KM; Winestone LE; Yin DE; Riches ML; Dandoy CE; Auletta JJ
Transplant Cell Ther; 2022 Oct; 28(10):696.e1-696.e7. PubMed ID: 35798233
[TBL] [Abstract][Full Text] [Related]
13. Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative.
Song Q; Bates B; Shao YR; Hsu FC; Liu F; Madhira V; Mitra AK; Bergquist T; Kavuluru R; Li X; Sharafeldin N; Su J; Topaloglu U
J Clin Oncol; 2022 May; 40(13):1414-1427. PubMed ID: 35286152
[TBL] [Abstract][Full Text] [Related]
14. Hospitalizations and Mortality From Non-SARS-CoV-2 Causes Among Medicare Beneficiaries at US Hospitals During the SARS-CoV-2 Pandemic.
Dang A; Thakker R; Li S; Hommel E; Mehta HB; Goodwin JS
JAMA Netw Open; 2022 Mar; 5(3):e221754. PubMed ID: 35262712
[TBL] [Abstract][Full Text] [Related]
15. Risk of COVID-19 Infections and of Severe Complications Among Survivors of Childhood, Adolescent, and Young Adult Cancer: A Population-Based Study in Ontario, Canada.
Gupta S; Sutradhar R; Alexander S; Science M; Lau C; Nagamuthu C; Agha M; Nathan PC; Hodgson D
J Clin Oncol; 2022 Apr; 40(12):1281-1290. PubMed ID: 35226549
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
